NasdaqCM - Delayed Quote • USD
Soligenix, Inc. (SNGX)
At close: 4:00 PM EDT
After hours: 5:58 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.2 | -0.2 | -0.81 | -0.68 |
Low Estimate | -0.2 | -0.2 | -0.81 | -0.68 |
High Estimate | -0.2 | -0.2 | -0.81 | -0.68 |
Year Ago EPS | -0.36 | -0.22 | -0.79 | -0.81 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 200k | 200k | 800k | 1M |
Low Estimate | 200k | 200k | 800k | 1M |
High Estimate | 200k | 200k | 800k | 1M |
Year Ago Sales | 200k | 207k | 840k | 800k |
Sales Growth (year/est) | 0.00% | -3.40% | -4.80% | 25.00% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -1.25 | -0.49 | -0.29 | -0.19 |
EPS Actual | -0.36 | -0.22 | -0.16 | -0.23 |
Difference | 0.89 | 0.27 | 0.13 | -0.04 |
Surprise % | 71.20% | 55.10% | 44.80% | -21.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.2 | -0.2 | -0.81 | -0.68 |
7 Days Ago | -0.2 | -0.2 | -0.81 | -0.68 |
30 Days Ago | -0.2 | -0.17 | -0.84 | -0.91 |
60 Days Ago | -0.2 | -0.17 | -0.84 | -0.91 |
90 Days Ago | -0.2 | -0.17 | -0.84 | -0.91 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | SNGX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 44.40% | -- | -- | 1.60% |
Next Qtr. | 9.10% | -- | -- | 10.50% |
Current Year | -2.50% | -- | -- | 5.20% |
Next Year | 16.00% | -- | -- | 13.30% |
Next 5 Years (per annum) | 1.00% | -- | -- | 11.22% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Related Tickers
LGVN Longeveron Inc.
1.9200
-4.48%
ONVO Organovo Holdings, Inc.
1.1000
-4.35%
PXMD PaxMedica, Inc.
0.7609
-0.29%
ALLR Allarity Therapeutics, Inc.
1.3900
-9.74%
RLYB Rallybio Corporation
1.7600
+5.39%
PALI Palisade Bio, Inc.
4.7100
-7.10%
ELYM Eliem Therapeutics, Inc.
3.8500
-7.89%
ADIL Adial Pharmaceuticals, Inc.
1.9300
-11.06%
JAGX Jaguar Health, Inc.
0.1569
-11.41%
SPRC SciSparc Ltd.
1.2300
-4.65%